Back to search
Terminal Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Terminal Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Terminal Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to evaluate the effects of cannabidiol in patients with end-stage metastatic castration-resistant prostate cancer (mCRPC). T…
This Phase 2, open label, study with safety lead in of oral talazoparib in combination with ZEN003694 given daily in 28-day cycles will enroll patients with rec…
A phase I/II, open-label, study to determine the safety and preliminary efficacy of orellanine in patients with metastatic clear-cell or papillary renal carcino…
This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in…
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlima…
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer a…
The study aims to find out if community health worker (CHW) support will improve palliative care outcomes in African American patients with advanced cancer, by…
Belantamab mafodotin is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb). Renal impairment…